Literature DB >> 18464045

The environmental genome project: reference polymorphisms for drug metabolism genes and genome-wide association studies.

Mark J Rieder1, Robert J Livingston, Ian B Stanaway, Deborah A Nickerson.   

Abstract

The Environmental Genome Project (EGP) has generated a comprehensive resource of commonly occurring single nucleotide polymorphisms (SNPs) in more than six hundred environmental response genes, including a number of drug metabolism genes. The gene-oriented sequence variation discovery carried out by the EGP is complementary to the HapMap and enables genome-wide association studies (GWAS) that survey a large portion of the known common variation. For GWAS focused on drug metabolism genes and phenotypes, it is important to know the proportion of common SNPs covered by the commercially available high-throughput genotyping chips. Herein, we review a subset of Phase I cytochrome P450 genes studied by the EGP, approaches to GWAS, and the sensitivity of available genotyping platforms to capture common sequence variation in this subset of drug metabolism genes.

Mesh:

Substances:

Year:  2008        PMID: 18464045     DOI: 10.1080/03602530801952880

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  9 in total

1.  Genome-wide association studies and beyond.

Authors:  John S Witte
Journal:  Annu Rev Public Health       Date:  2010       Impact factor: 21.981

2.  Assessment of a pharmacogenomic marker panel in a polypharmacy population identified from electronic medical records.

Authors:  Matthew T Oetjens; Joshua C Denny; Marylyn D Ritchie; Niloufar B Gillani; Danielle M Richardson; Nicole A Restrepo; Jill M Pulley; Holli H Dilks; Melissa A Basford; Erica Bowton; Dan R Masys; Russell A Wilke; Dan M Roden; Dana C Crawford
Journal:  Pharmacogenomics       Date:  2013-05       Impact factor: 2.533

3.  Genetic Variations in Telomere Maintenance, with Implications on Tissue Renewal Capacity and Chronic Disease Pathologies.

Authors:  M A Trudeau; J M Y Wong
Journal:  Curr Pharmacogenomics Person Med       Date:  2010-03-01

4.  A guide to the current Web-based resources in pharmacogenomics.

Authors:  Dylan M Glubb; Steven W Paugh; Ron H N van Schaik; Federico Innocenti
Journal:  Methods Mol Biol       Date:  2013

5.  Future health applications of genomics: priorities for communication, behavioral, and social sciences research.

Authors:  Colleen M McBride; Deborah Bowen; Lawrence C Brody; Celeste M Condit; Robert T Croyle; Marta Gwinn; Muin J Khoury; Laura M Koehly; Bruce R Korf; Theresa M Marteau; Kenneth McLeroy; Kevin Patrick; Thomas W Valente
Journal:  Am J Prev Med       Date:  2010-05       Impact factor: 5.043

6.  Fine-mapping reveals novel alternative splicing of the dopamine transporter.

Authors:  Michael E Talkowski; Kathleen L McCann; Michael Chen; Lora McClain; Mikhil Bamne; Joel Wood; Kodavali V Chowdari; Annie Watson; Konasale M Prasad; George Kirov; Lyudmilla Georgieva; Draga Toncheva; Hader Mansour; David A Lewis; Michael Owen; Michael O'Donovan; Panagiotis Papasaikas; Patrick Sullivan; Douglas Ruderfer; Jeffrey K Yao; Sherry Leonard; Pramod Thomas; Fabio Miyajima; John Quinn; A Javier Lopez; Vishwajit L Nimgaonkar
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-10-18       Impact factor: 3.568

7.  Cancer-associated variants and a common polymorphism of MUTYH exhibit reduced repair of oxidative DNA damage using a GFP-based assay in mammalian cells.

Authors:  Alan G Raetz; Yali Xie; Sucharita Kundu; Megan K Brinkmeyer; Cindy Chang; Sheila S David
Journal:  Carcinogenesis       Date:  2012-08-26       Impact factor: 4.944

Review 8.  Genetic variation in the chemokine receptor 5 gene and course of HIV infection; review on genetics and immunological aspect.

Authors:  M K Verma; S Shakya
Journal:  Genes Dis       Date:  2020-04-18

9.  Knowledge building insights on biomarkers of arsenic toxicity to keratinocytes and melanocytes.

Authors:  Raphael D Isokpehi; Udensi K Udensi; Matthew N Anyanwu; Andreas N Mbah; Matilda O Johnson; Kafui Edusei; Michael A Bauer; Roger A Hall; Omotayo R Awofolu
Journal:  Biomark Insights       Date:  2012-10-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.